GlassScriptPhysician profile
Emalee K Singer
NPI 1710428891
$8,442.14
in general payments reported to CMS, 2019-2025
30 companies · $2,874 in 2025
The $2,874 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,109 · 2022: $925 · 2023: $1,501 · 2024: $2,033 · 2025: $2,874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,941 · Education: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,941.01 |
| Education | $467.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,812.65 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Abbvie INC. | $1,343.52 | 2021-2025 | |
| Genzyme Corporation | $793.64 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $663.02 | 2021-2025 | Sotyktu |
| Lilly USA, LLC | $588.36 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Sun Pharmaceutical Industries INC. | $539.39 | 2021-2025 | Ilumya |
| Amgen INC. | $370.29 | 2022-2025 | Otezla, Otezla |
| Ucb, INC. | $360.06 | 2024-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $327.86 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $292.45 | 2021-2025 | Dupixent |
| Organon LLC | $274.11 | 2025 | Vtama |
| Dermavant Sciences, INC. | $193.95 | 2022-2024 | Vtama |
| Galderma Laboratories, L.P. | $189.95 | 2021-2025 | Nemluvio, Aklief |
| Hill Dermaceuticals, INC. | $108.79 | 2025 | Tolak |
| Janssen Scientific Affairs, LLC | $93.34 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $69.02 | 2022-2024 | Klisyri |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $61.64 | 2021-2022 | |
| Leo Pharma INC. | $48.82 | 2022-2023 | Adbry |
| Arcutis Biotherapeutics, INC. | $39.60 | 2024-2025 | Zoryve |
| Mimedx Group, INC. | $35.83 | 2024-2025 | |
| Biofrontera INC. | $32.58 | 2022-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.06 | 2023 | Spevigo |
| Pfizer INC. | $27.14 | 2021-2022 | |
| Journey Medical Corporation | $26.78 | 2022-2024 | |
| Krystal Biotech INC | $26.70 | 2024 | Vyjuvek |
| Paratek Pharmaceuticals, INC. | $20.35 | 2025 | Nuzyra |
| Bioventus LLC | $18.53 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $18.23 | 2024 | |
| Smith+Nephew, INC. | $17.94 | 2024 | Grafix Pl |
| Verrica Pharmaceuticals INC. | $15.54 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emalee Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.